Skip to content
20-F/A

Annual Report (Foreign)

Medifocus Inc.

0001511164-17-000456

← back to feed
Filed
Aug 4, 2017 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Mar 31, 2017 184.98M sh
Current Liabilities restated FY 2017 · Mar 31, 2016 $9.68M
Total Liabilities restated FY 2017 · Mar 31, 2016 $9.97M
Current Assets restated FY 2017 · Mar 31, 2016 $851.35K
Total Assets restated FY 2017 · Mar 31, 2016 $3.15M
Operating Income FY 2017 · Mar 31, 2016 −$3.22M
Operating Income FY 2017 · Mar 31, 2015 −$4.09M
Operating Cash Flow FY 2017 · Mar 31, 2015 −$2.82M
Sga Expense FY 2017 · Mar 31, 2015 $2.7M
Rd Expense FY 2017 · Mar 31, 2015 $399.21K
Net Income FY 2017 · Mar 31, 2015 −$5.97M
Gross Profit FY 2017 · Mar 31, 2015 $563.99K
Cost Of Revenue FY 2017 · Mar 31, 2015 $3.66M
Cash And Equivalents FY 2017 · Mar 31, 2014 $1.29M